Form 4: Guardant Health Executive Reports Stock Transactions
Insider Transaction Report
Guardant Health Chief People Officer Terilyn J. Monroe reported transactions involving restricted stock units and common stock.
Summary
- Terilyn J. Monroe, Chief People Officer of Guardant Health, Inc., reported several transactions on April 1, 2026.
- These transactions involved the acquisition of common stock through the vesting of restricted stock units (RSUs) and the retention of shares by the company for tax withholding obligations.
- A total of 2,660 shares were acquired and 5,359 shares were acquired, with a portion of these retained for tax purposes.
- Additionally, 4,187 shares were disposed of at a price of $91.15 per share.
- Following these transactions, Monroe beneficially owns 23,650 shares directly and 29,009 shares directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it represents routine insider stock transactions related to executive compensation and does not provide new financial or strategic information.
Positives
- Vesting of restricted stock units indicates continued equity-based compensation for the Chief People Officer.
- The company's retention of shares for tax withholding is a standard and efficient practice.
Negatives
- 4,187 shares were disposed of at a price of $91.15, indicating a sale of stock.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports past transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions and do not typically contain strategic updates. The transactions reported by Guardant Health's Chief People Officer are standard for executive compensation and equity management.
Stakeholder Impact
- Shareholders: The disposal of shares by an executive may be interpreted in various ways, though it is common for executives to sell shares for personal liquidity or diversification. The retention of shares for tax withholding is a standard practice.
Key Dates
| Date | Description |
|---|---|
| 04/01/2026 | Date of earliest transaction reported and transaction date for stock acquisitions and disposals. |
| 04/02/2026 | Date of signature for the filing. |
Keywords
Guardant Health, Form 4, SEC Filing, Stock Transaction, Restricted Stock Units, Executive Compensation, Terilyn J. Monroe, Chief People Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.